121 related articles for article (PubMed ID: 2881026)
1. The integrated effect of adrenergic blockade on glucose, fatty acid, and glycerol kinetics: responses in the basal state and during hormonal control with somatostatin-hormonal infusion.
Shaw JH; Wolfe RR
J Surg Res; 1987 Mar; 42(3):257-72. PubMed ID: 2881026
[TBL] [Abstract][Full Text] [Related]
2. Investigation of kinetics of integrated metabolic response to adrenergic blockade in conscious dogs.
Wolfe RR; Durkot MJ; Wolfe MH
Am J Physiol; 1981 Nov; 241(5):E385-95. PubMed ID: 6118065
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of plasma free fatty acids on glucose production in the conscious dog.
Wolfe RR; Shaw JH
Am J Physiol; 1984 Feb; 246(2 Pt 1):E181-6. PubMed ID: 6141738
[TBL] [Abstract][Full Text] [Related]
4. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
5. Influence of beta-hydroxybutyrate infusion on glucose and free fatty acid metabolism in dogs.
Shaw JH; Wolfe RR
Am J Physiol; 1984 Dec; 247(6 Pt 1):E756-64. PubMed ID: 6095672
[TBL] [Abstract][Full Text] [Related]
6. Effect of epinephrine infusion and adrenergic blockade on glucose oxidation in conscious dogs.
Wolfe RR; Shaw JH
Metabolism; 1986 Jul; 35(7):673-8. PubMed ID: 3523120
[TBL] [Abstract][Full Text] [Related]
7. Role of hepatic alpha- and beta-adrenergic receptor stimulation on hepatic glucose production during heavy exercise.
Coker RH; Krishna MG; Lacy DB; Bracy DP; Wasserman DH
Am J Physiol; 1997 Nov; 273(5):E831-8. PubMed ID: 9374667
[TBL] [Abstract][Full Text] [Related]
8. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog.
Shulman GI; Williams PE; Liljenquist JE; Lacy WW; Keller U; Cherrington AD
Metabolism; 1980 Apr; 29(4):317-20. PubMed ID: 6103495
[TBL] [Abstract][Full Text] [Related]
9. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs.
Sakurai Y; Zhang XJ; Wolfe RR
Am J Physiol; 1996 May; 270(5 Pt 1):E864-72. PubMed ID: 8967476
[TBL] [Abstract][Full Text] [Related]
10. Energy and substrate kinetics and oxidation during ketone infusion in septic dogs: role of changes in insulin and glucagon.
Shaw JH; Wolfe RR
Circ Shock; 1984; 14(1):63-79. PubMed ID: 6149025
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM.
Bolinder J; Sjöberg S; Arner P
Diabetologia; 1996 Jul; 39(7):845-53. PubMed ID: 8817110
[TBL] [Abstract][Full Text] [Related]
12. Metabolic intervention in surgical patients: the effect of alpha- or beta-blockade on glucose and protein metabolism in surgical patients receiving total parenteral nutrition.
Shaw JH; Holdaway CM; Humberstone DA
Surgery; 1988 May; 103(5):520-5. PubMed ID: 2896394
[TBL] [Abstract][Full Text] [Related]
13. Glucose and FFA kinetics in sepsis: role of glucagon and sympathetic nervous system activity.
Wolfe RR; Shaw JH
Am J Physiol; 1985 Feb; 248(2 Pt 1):E236-43. PubMed ID: 3881989
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits--influences of selective blocking drugs.
Knudtzon J
Acta Physiol Scand; 1984 Mar; 120(3):353-61. PubMed ID: 6146241
[TBL] [Abstract][Full Text] [Related]
15. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
16. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog.
Chu CA; Sindelar DK; Igawa K; Sherck S; Neal DW; Emshwiller M; Cherrington AD
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E463-73. PubMed ID: 10913048
[TBL] [Abstract][Full Text] [Related]
17. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
18. Acute metabolic effects of adrenergic agents in swine.
Mersmann HJ
Am J Physiol; 1987 Jan; 252(1 Pt 1):E85-95. PubMed ID: 2880510
[TBL] [Abstract][Full Text] [Related]
19. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man.
Weiss M; Keller U; Stauffacher W
Diabetes; 1984 Aug; 33(8):738-44. PubMed ID: 6146545
[TBL] [Abstract][Full Text] [Related]
20. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
Hendrick GK; Frizzell RT; Cherrington AD
Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
